hotspot -WSS

hotspot

author：comprehensive 2025-09-28 02:31:28 - browse：41

a photo of the federal trade commission building — Alex Brandon/AP

The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider.

Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player, Novant, even more powerful. And even though smaller deals like this get less attention than huge, 100-plus hospital mergers, they can still drive up people’s insurance premiums and medical bills.

In this case, Novant, a nonprofit system with $7.6 billion in 2022 revenue, plans to buy two hospitals in the same county from the for-profit chain Community Health Systems for $320 million. The two hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only about a 25-minute drive from one another. A Novant spokesperson called the FTC’s position flawed and said the system will pursue available legal responses. CHS spokesperson Tomi Galin wrote in an email that a judge will make the final determination on whether the transaction can proceed and thanked staff for continuing to deliver quality care during the regulatory process.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Senate HELP committee spars over health care workforce policies

knowledge

WSS

Readout LOUD podcast: possible new ALS drug, artificial wombs

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Biotech companies concerned about China biosecurity crackdown

AstraZeneca loses challenge to Medicare drug price negotiation

It's been 20 years since Dolly the sheep. Where's my clone?

Microbiome research is starting to find links to chronic diseases

entertainment

hotspot

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Why getting cancer drugs just got harder for rural patients

The high cost of giving birth even with insurance

FogPharma raises $145 million in rare Series E round

Moonlake's readout produced a cash windfall. Risks remain

FogPharma raises $145 million in rare Series E round

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Covid isolation guidance eased by the CDC

Medical records are filled with copy

Congress gives doctors Medicare pay bump

Wikipedia

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Change Healthcare cyberattack outage could last weeks

Microbiome research is starting to find links to chronic diseases

Biotech companies concerned about China biosecurity crackdown

In search for therapies for solid tumors, companies turn to claudin

An inside look at PIPEs, biotech's buzzy new financing tool

focus

knowledge

hotspot

focus